Sanofi (SNY) EPS (Basic) (2009 - 2026)

Sanofi has disclosed EPS (Basic) across 18 years of filings, most recently posting $0.33 for Q2 2026.

• In Q2 2026, EPS (Basic) fell 91.06% year-over-year to $0.33; the TTM figure through Jun 2026 stood at $3.82 (down 53.64% YoY), while the FY2025 annual figure was $7.45, up 54.97% from the prior year.
• EPS (Basic) came in at $0.33 for Q2 2026 at Sanofi, down from $1.55 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $8.25 in Q3 2025 to a low of -$6.31 in Q4 2025.
• Average EPS (Basic) over 5 years is $1.52, with a median of $1.56 recorded in 2025.
• The largest YoY upside for EPS (Basic) was 281.65% in 2025 against a maximum downside of 1580.29% in 2025.
• Over 5 years, EPS (Basic) stood at $4.29 in 2022, then slumped by 111.13% to -$0.48 in 2023, then surged by 189.32% to $0.43 in 2024, then slumped by 1580.29% to -$6.31 in 2025, then surged by 105.18% to $0.33 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $0.33 in Q2 2026, $1.55 in Q1 2026, and -$6.31 in Q4 2025.